Emergent Biosolutions Shares Outstanding 2007-2019 | EBS

Emergent Biosolutions shares outstanding from 2007 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Emergent Biosolutions Annual Shares Outstanding
(Millions of Shares)
2018 51
2017 50
2016 49
2015 47
2014 46
2013 37
2012 36
2011 36
2010 33
2009 31
2008 30
2007 30
2006 25
2005 23
Emergent Biosolutions Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 52
Q2 2019 52
Q1 2019 51
Q4 2018 51
Q3 2018 52
Q2 2018 51
Q1 2018 50
Q4 2017 50
Q3 2017 50
Q2 2017 50
Q1 2017 50
Q4 2016 49
Q3 2016 49
Q2 2016 40
Q1 2016 48
Q4 2015 47
Q3 2015 48
Q2 2015 47
Q1 2015 38
Q4 2014 46
Q3 2014 47
Q2 2014 38
Q1 2014 37
Q4 2013 37
Q3 2013 37
Q2 2013 37
Q1 2013 36
Q4 2012 36
Q3 2012 37
Q2 2012 37
Q1 2012 36
Q4 2011 36
Q3 2011 36
Q2 2011 37
Q1 2011 35
Q4 2010 33
Q3 2010 32
Q2 2010 32
Q1 2010 31
Q4 2009 31
Q3 2009 32
Q2 2009 31
Q1 2009 31
Q4 2008 30
Q3 2008 31
Q2 2008 30
Q1 2008 30
Q4 2007 30
Q3 2007 30
Q2 2007 29
Q1 2007 28
Q4 2006 25
Q3 2006 24
Q2 2006 22
Q1 2006 22
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.787B $0.782B
Emergent BioSolutions Inc. is strongly committed to the highest standards of ethical conduct and corporate governance. These standards are consistent with their corporate culture. The company understands that adhering to sound principles of corporate governance is critical to earning and maintaining the trust of their customers, employees and shareholders. The foundation of the corporate governance principles and practices are built on their reputation for openness, integrity and accountability. These are the principles that guide Emergent BioSolutions everyday. They have in place policies and practices to ensure that their Company is managed with integrity and in their shareholders' best interests. In addition, they are committed to meeting the requirements of federal and state law and the rules of the New York Stock Exchange.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.338B 15.94
CSL (CSLLY) Australia $86.171B 0.00
Gilead Sciences (GILD) United States $84.676B 10.49
Vertex Pharmaceuticals (VRTX) United States $56.411B 57.58
Biogen (BIIB) United States $53.330B 9.15
Illumina (ILMN) United States $48.009B 52.68
Regeneron Pharmaceuticals (REGN) United States $40.144B 17.58
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.891B 12.29
Incyte (INCY) United States $20.418B 47.40
Seattle Genetics (SGEN) United States $19.560B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.114B 0.00
Genmab (GNMSF) Denmark $14.371B 63.48
BioMarin Pharmaceutical (BMRN) United States $14.172B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.458B 0.00
Galapagos (GLPG) Belgium $11.831B 30.48
Exact Sciences (EXAS) United States $10.931B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
QIAGEN (QGEN) Netherlands $9.363B 30.53
BeiGene (BGNE) Cayman Islands $8.766B 0.00
Bio-Techne Corp (TECH) United States $8.356B 55.93
Amarin (AMRN) Ireland $8.062B 0.00
Sarepta Therapeutics (SRPT) United States $7.883B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.382B 0.00
Guardant Health (GH) United States $6.775B 0.00
Medicines (MDCO) United States $6.709B 0.00
BioNTech SE (BNTX) Germany $6.562B 0.00
Moderna (MRNA) United States $6.258B 0.00
Reata Pharmaceuticals (RETA) United States $6.139B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.973B 15.19
ARGENX SE-ADR (ARGX) Netherlands $5.822B 0.00
Exelixis (EXEL) United States $5.114B 14.39
Repligen (RGEN) United States $4.699B 85.16
China Biologic Products (CBPO) China $4.611B 25.97
Ascendis Pharma (ASND) Denmark $4.463B 0.00
Spark Therapeutics (ONCE) United States $4.281B 0.00
MorphoSys AG (MOR) Germany $4.273B 0.00
Bluebird Bio (BLUE) United States $4.238B 0.00
Mirati Therapeutics (MRTX) United States $4.100B 0.00
Immunomedics (IMMU) United States $4.037B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.724B 0.00
Adaptive Biotechnologies (ADPT) United States $3.642B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.629B 0.00
Blueprint Medicines (BPMC) United States $3.462B 0.00
Alkermes (ALKS) Ireland $3.425B 0.00
MyoKardia (MYOK) United States $3.096B 0.00
Genmab (GMAB) Denmark $3.091B 6.37
Halozyme Therapeutics (HALO) United States $2.789B 0.00
UniQure (QURE) Netherlands $2.748B 0.00
NeoGenomics (NEO) United States $2.711B 144.28
Acceleron Pharma (XLRN) United States $2.650B 0.00
Amicus Therapeutics (FOLD) United States $2.487B 0.00
Arena Pharmaceuticals (ARNA) United States $2.451B 5.70
Zai Lab (ZLAB) China $2.446B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.399B 0.00
RA PHARMCTL INC (RARX) United States $2.221B 0.00
Insmed (INSM) United States $2.047B 0.00
Myriad Genetics (MYGN) United States $1.861B 27.50
Ligand Pharmaceuticals (LGND) United States $1.858B 35.74
Momenta Pharmaceuticals (MNTA) United States $1.769B 0.00
Denali Therapeutics (DNLI) United States $1.753B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.742B 0.00
Epizyme (EPZM) United States $1.693B 0.00
Akcea Therapeutics (AKCA) United States $1.661B 0.00
REGENXBIO (RGNX) United States $1.572B 0.00
Zymeworks (ZYME) Canada $1.562B 0.00
Editas Medicine (EDIT) United States $1.556B 0.00
Fate Therapeutics (FATE) United States $1.460B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.434B 0.00
Principia Biopharma (PRNB) United States $1.376B 0.00
Alector (ALEC) United States $1.353B 0.00
Innoviva (INVA) United States $1.347B 3.97
Arvinas (ARVN) United States $1.312B 0.00
Athenex (ATNX) United States $1.291B 0.00
Coherus BioSciences (CHRS) United States $1.232B 0.00
Sangamo Therapeutics (SGMO) United States $1.195B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
WAVE Life Sciences (WVE) Singapore $1.112B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.079B 0.00
Zealand Pharma (ZEAL) Denmark $0.974B 0.00
Pharming Group (PHGUF) Netherlands $0.967B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.943B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.928B 7.80
Codexis (CDXS) United States $0.913B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.870B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.846B 0.00
Vericel (VCEL) United States $0.827B 308.33
Intellia Therapeutics (NTLA) United States $0.817B 0.00
MiMedx (MDXG) United States $0.808B 0.00
Twist Bioscience (TWST) United States $0.806B 0.00
Anika Therapeutics (ANIK) United States $0.793B 25.71
ANI Pharmaceuticals (ANIP) United States $0.738B 12.59
Heska (HSKA) United States $0.732B 187.08
Revance Therapeutics (RVNC) United States $0.731B 0.00
Adverum Biotechnologies (ADVM) United States $0.722B 0.00
UROGEN PHARMA (URGN) United States $0.719B 0.00
DBV Technologies S.A (DBVT) France $0.718B 0.00
Cara Therapeutics (CARA) United States $0.651B 0.00
Mesoblast (MESO) Australia $0.648B 0.00
Intra-Cellular Therapies (ITCI) United States $0.638B 0.00
Cellectis S.A (CLLS) France $0.632B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.630B 0.00
Sorrento Therapeutics (SRNE) United States $0.627B 0.00
Kadmon Holdings (KDMN) United States $0.594B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
Clovis Oncology (CLVS) United States $0.587B 0.00
AC Immune SA (ACIU) Switzerland $0.586B 13.55
GENFIT S.A (GNFT) France $0.583B 0.00
PHARMA MAR SA (PHMMF) Spain $0.580B 0.00
Retrophin (RTRX) United States $0.572B 0.00
BioDelivery Sciences (BDSI) United States $0.572B 0.00
Cytokineticsorporated (CYTK) United States $0.569B 0.00
Dynavax Technologies (DVAX) United States $0.553B 0.00
Agenus (AGEN) United States $0.537B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.529B 3.66
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Prothena (PRTA) Ireland $0.510B 0.00
Stemline Therapeutics (STML) United States $0.497B 0.00
Precision BioSciences (DTIL) United States $0.482B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
PDL BioPharma (PDLI) United States $0.410B 10.27
Bellus Health (BLU) Canada $0.386B 0.00
Merus (MRUS) Netherlands $0.383B 0.00
Arcus Biosciences (RCUS) United States $0.375B 0.00
AnaptysBio (ANAB) United States $0.374B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.365B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.359B 0.00
OSMOTICA PHARM (OSMT) United States $0.347B 0.00
Pfenex (PFNX) United States $0.332B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
Gritstone Oncology (GRTS) United States $0.330B 0.00
Avid Bioservices (CDMO) United States $0.329B 0.00
Starpharma Holdings (SPHRY) Australia $0.311B 0.00
Kamada (KMDA) Israel $0.310B 9.06
Geron (GERN) United States $0.306B 0.00
Kindred Biosciences (KIN) United States $0.304B 0.00
Puma Biotechnology (PBYI) United States $0.299B 0.00
CytomX Therapeutics (CTMX) United States $0.289B 0.00
Compugen (CGEN) Israel $0.279B 0.00
Cel-Sci (CVM) United States $0.269B 0.00
Cue Biopharma (CUE) United States $0.268B 0.00
Seres Therapeutics (MCRB) United States $0.266B 0.00
Scholar Rock Holding (SRRK) United States $0.260B 0.00
Albireo Pharma (ALBO) United States $0.258B 0.00
MannKind (MNKD) United States $0.252B 0.00
ADMA Biologics Inc (ADMA) United States $0.246B 0.00
Inovio Pharmaceuticals (INO) United States $0.246B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.241B 0.00
Theratechnologies (THTX) Canada $0.236B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
Sutro Biopharma (STRO) United States $0.236B 0.00
ChromaDex (CDXC) United States $0.229B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Biofrontera AG (BFRA) Germany $0.221B 0.00
Exicure (XCUR) United States $0.220B 0.00
XOMA (XOMA) United States $0.218B 0.00
Senesco Technologies (ELOX) United States $0.218B 0.00
IVERIC Bio (ISEE) United States $0.217B 0.00
Spero Therapeutics (SPRO) United States $0.217B 0.00
Protagonist Therapeutics (PTGX) United States $0.208B 0.00
Athersys (ATHX) United States $0.205B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Mersana Therapeutics (MRSN) United States $0.203B 0.00
Syros Pharmaceuticals (SYRS) United States $0.192B 0.00
Palatin Technologies (PTN) United States $0.182B 4.96
Proteostasis Therapeutics (PTI) United States $0.180B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.179B 0.00
Affimed (AFMD) Germany $0.172B 0.00
NantKwest (NK) United States $0.165B 0.00
ARAVIVE, INC (ARAV) United States $0.165B 0.00
Cerecor (CERC) United States $0.164B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.160B 0.00
Dyadic (DYAI) United States $0.160B 0.00
Alcobra (ARCT) United States $0.159B 0.00
CorMedix Inc (CRMD) United States $0.159B 0.00
VBI Vaccines (VBIV) United States $0.156B 0.00
Abeona Therapeutics (ABEO) United States $0.150B 0.00
Arsanis (XFOR) United States $0.150B 0.00
Five Prime Therapeutics (FPRX) United States $0.142B 0.00
Aptinyx (APTX) United States $0.137B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.137B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.136B 0.00
Arbutus Biopharma (ABUS) Canada $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
TELA Bio (TELA) United States $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Prometic Life Sciences (LMNL) Canada $0.132B 0.00
Nicox SA (NICXF) France $0.126B 0.00
Enzo Biochem (ENZ) United States $0.125B 0.00
Fortress Biotech (FBIO) United States $0.123B 0.00
SESEN BIO, INC (SESN) United States $0.122B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.119B 0.00
Windtree Therapeutics (WINT) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.118B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.115B 0.00
BioTime (LCTX) United States $0.111B 5.72
Novavax (NVAX) United States $0.111B 0.00
Menlo Therapeutics (MNLO) United States $0.108B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.102B 0.00
Verastem (VSTM) United States $0.102B 0.00
Strongbridge Biopharma (SBBP) United States $0.096B 2.57
Aduro Biotech (ADRO) United States $0.095B 0.00
PHASEBIO PHARMA (PHAS) United States $0.092B 0.00
Antibe Therapeutics (ATBPF) Canada $0.090B 0.00
Emmaus Life Sciences (EMMA) United States $0.090B 0.00
Adocia (ADOCY) France $0.086B 0.00
OvaScience (MLND) United States $0.085B 0.00
Acorda Therapeutics (ACOR) United States $0.083B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Synlogic (SYBX) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.077B 0.00
Selecta Biosciences (SELB) United States $0.075B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.075B 0.00
Liquidia Technologies (LQDA) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.067B 0.00
Trevena (TRVN) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.064B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.058B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.051B 0.00
Curis (CRIS) United States $0.050B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
Checkpoint Therapeutics (CKPT) United States $0.048B 0.00
Protalix BioTherapeutics (PLX) Israel $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
Alimera Sciences (ALIM) United States $0.045B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Orgenesis (ORGS) United States $0.042B 2.71
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Apricus Biosciences (SEEL) United States $0.038B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Stellar Biotechnologies (EDSA) Canada $0.034B 0.00
Evogene (EVGN) Israel $0.033B 0.00
Celsion (CLSN) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.033B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
Bionano Genomics (BNGO) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Novogen (KZIA) Australia $0.027B 0.00
BioCardia (BCDA) United States $0.026B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.026B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Soligenix (SNGX) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.020B 0.00
Signal Genetics (MGEN) United States $0.019B 0.00
VistaGen Therapeutics (VTGN) United States $0.019B 0.00
Unum Therapeutics (UMRX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Advaxis (ADXS) United States $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.012B 0.00
TrovaGene (TROV) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
IBio (IBIO) United States $0.009B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00